Tumor Board Review. Guideline and Case Reviews in Oncology

Description

Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists — both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam.

The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several “tumor board style” illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process.

NEW TO THE SECOND EDITION OF TUMOR BOARD REVIEW:

• Presents the most recent guidelines and management standards in user-friendly format
• Focuses on current indications, use of new drugs, and new treatment of side effects
• Includes new FDA-approved drugs and guidelines
• Offers approximately 250 multiple-choice questions and answers

Praise for the First Edition

“As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information…by the time the book is [published]…it is outdated.” [Tumor Board Review] is fresh and just out of the oven…I haven’t seen any book in oncology like this so far…I think my investment in this book was wise and worth it.” — Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center

Table of Contents

Contributors
Preface to the Second Edition
Preface to the First Edition

1. Head and Neck Cancer
Assuntina G. Sacco, Irina Y. Dobrosotskaya, and Francis P. Worden
2. Thyroid Cancer
Alexander T. Pearson, Kevin McDonnell, and Megan Rist Haymart
3. Non-Small-Cell Lung Cancer
Kunal C. Kadakia and Nithya Ramnath
4. Small Cell Lung Cancer
Igor I. Rybkin, Binu Malhotra, and Gregory P. Kalemkerian
5. Breast Cancer
Priya Gomathi Kumaravelu, Aihua Edward Yen, Michelina M. Cairo, Mothaffar F. Rimawi, and Polly A. Niravath
6. Esophageal Cancer
Ray Esper and Susan G. Urba
7. Gastric Cancer
Josh Wilfong and Mark M. Zalupski
8. Pancreatic Cancer
Yue C. Wang, Dongxin Liu, Ahmed A. Eid, and Aihua Edward Yen
9. Neuroendocrine Cancer
Daniel Da Graca, Mariela Blum, Garrett R. Lynch, and Jun Zhang
10. Hepatobiliary Cancers
Ghana Kang, Ahmed Awais, Paul Zhang, and Yvonne Sada
11. Colorectal Cancer
Jasmine Kamboj, Yvonne Sada, and Benjamin L. Musher
12. Anal Cancer
Ruiling Xu Yuan, Muhammad A. Tarakji, and Elizabeth Yu Chiao
13. Prostate Cancer
Leonel F. Hernandez-Aya, Jingsong Zhang, Kathleen A. Cooney, and Maha H. Hussain
14. Testicular Cancer
Diego J. Bedoya, Martha Pritchett Mims, Shamail Butt, and Courtney N. Miller-Chism
15. Kidney Cancer
Benjamin Y. Scheier, Jenny J. Kim, and Bruce G. Redman
16. Bladder Cancer
Erin F. Cobain, Colin J. Mooney, and David C. Smith
17. Cervical Cancer
Andrei Marconescu, Celestine S. Tung, Shan Guo, Concepcion R. Diaz-Arrastia, and Marian Yvette Williams-Brown
18. Uterine Cancer
Kiran Naqvi, Atisha P. Manhas, and Matthew L. Anderson
19. Ovarian Cancer
Lan Coffman, Karen McLean, and Ronald J. Buckanovich
20. Melanoma
Ann W. Silk, Kevin McDonnell, and Christopher D. Lao
21. Bone Sarcoma
Elizabeth J. Davis and Scott M. Schuetze
22. Soft Tissue Sarcoma
Dana E. Angelini and Rashmi Chugh
23. Primary Brain Tumors
Abhishek Marballi, Janet Wang, and Pamela New
24. Cancer of Unknown Primary
Miho Teruya, Yuval Raizen, and Gerald S. Cyprus
25. Hodgkin Lymphoma
Jesus H. Hermosillo-Rodriguez, Polly A. Niravath, Catherine M. Bollard, and Carlos A. Ramos
26. Non-Hodgkin Lymphoma
Premal Lulla and Sarvari Yellapragada
27. Multiple Myeloma
Vedran Radojcic, Erlene K. Seymour, and Daniel Lebovic
28. Acute Lymphoblastic Leukemia
Musa Yilmaz and Mark M. Udden
29. Acute Myelogenous Leukemia
Kavitha Beedupalli and Gustavo Rivero
30. Chronic Myeloid Leukemia
Alissa A. Weber, Rami N. Khoriaty, and Moshe Talpaz
31. Chronic Lymphocytic Leukemia
Rami N. Khoriaty and Sami N. Malek
32. Myelodysplastic Syndrome
Sumana Devata, John Magenau, and Dale Bixby

Answers
Index